TARA SEC Filings: 8-K, 10-Q, S-3 & 424B

Financials

TYPE

HEADLINE

FILED AT

News

TYPE

HEADLINE

FILED AT

8-K

Protara Therapeutics Announces Third Quarter 2026 Financial Results and Business Updates

Nov 6, 2026

8-K

Protara Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Aug 11, 2026

8-K

Protara Therapeutics Announces Resignation of Chief Medical Officer

Jun 29, 2026

8-K

Protara Therapeutics, Inc. Announces Results of 2026 Annual Meeting of Stockholders

Jun 15, 2026

8-K

Protara Therapeutics Announces First Quarter 2026 Financial Results and Business Update

May 13, 2026

8-K

Protara Therapeutics Announces Positive Phase 2 ADVANCED-2 Trial Results and Sets Exercise Deadline for April 2024 Warrants

Mar 30, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B5

[No Baby Shelf]* May 2026 ATM | Offering amount: $100,000,000 | Bank: TD Cowen

May 28, 2026

424B7

SHARE RESALE REGISTRATION | Shares: 21,686,760

Mar 6, 2026

424B7

SHARE RESALE REGISTRATION | Shares: 21,686,760

Feb 2, 2026

424B7

SHARE RESALE REGISTRATION | Shares amount: 21,686,760 | Warrants amount: 11,843,380

Dec 9, 2025

424B5

REGISTERED OFFERING

Dec 5, 2025

424B5

PENDING FIXED PRICE OFFERING | Bank: J.P. Morgan, TD Cowen, Piper Sandler

Dec 4, 2025

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Aug 11, 2026

S-3

May 2026 SHELF + ATM

May 13, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Aug 11, 2025

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Mar 5, 2025

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Aug 6, 2024

S-3

SHARE RESALE REGISTRATION | Shares amount: 21,686,760 | Warrants amount: 12,643,380 EFFECTIVE

May 2, 2024

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

SCHEDULE 13G/A

Janus Henderson Group Ltd. (Filed by)

Aug 13, 2026

SCHEDULE 13G/A

MILLENNIUM MANAGEMENT LLC (Filed by)

Jul 7, 2026

Shefferman Jesse (Reporting)

Jul 1, 2026

144

Form 144 - Report of proposed sale of securities

Jun 29, 2026

Levy Richard S (Reporting)

Jun 16, 2026

Solomon Michael Edward (Reporting)

Jun 16, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

May 26, 2026

CORRESP

Form CORRESP - Correspondence

May 20, 2026

LETTER

Form UPLOAD - SEC-generated letter

May 19, 2026

EFFECT

Form EFFECT - Notice of Effectiveness

May 10, 2024

CORRESP

Form CORRESP - Correspondence

May 7, 2024

LETTER

Form UPLOAD - SEC-generated letter

May 7, 2024

Protara Therapeutics, Inc. TARA · SEC Filings